Aligos Therapeutics Inc
F:5WK0
Aligos Therapeutics Inc
F:5WK0
Price:
5.36
EUR
-2.55%
Market Closed
Market Cap:
€33m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aligos Therapeutics Inc
F:5WK0
|
US |
|
J
|
Jet2 PLC
OTC:DRTGF
|
UK |
|
T
|
TriMas Corp
F:MQ1
|
US |
|
Engie SA
F:GZF
|
FR |
|
RXO Inc
F:N9Q
|
US |
|
Sun Hung Kai Properties Ltd
OTC:SUHJF
|
HK |
|
M
|
Mabion SA
WSE:MAB
|
PL |
|
B
|
Banca Popolare Di Sondrio SpA
SWB:593
|
IT |
Wall St Price Targets
5WK0 Price Targets Summary
Aligos Therapeutics Inc
Aligos Therapeutics Inc
Wall Street analysts forecast 5WK0 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 5WK0 is 36.36 EUR with a low forecast of 18.7 EUR and a high forecast of 48.61 EUR.
Lowest Forecast
Price Target
18.7
EUR
249% Upside
Average Forecast
Price Target
36.36
EUR
578% Upside
Highest Forecast
Price Target
48.61
EUR
807% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5WK0's stock price target?
Price Target
36.36
EUR
36.36
EUR
According to Wall Street analysts, the average 1-year price target for 5WK0 is 36.36 EUR with a low forecast of 18.7 EUR and a high forecast of 48.61 EUR.
What is the Revenue forecast for Aligos Therapeutics Inc?
Projected CAGR
118%
118%
The compound annual growth rate for Revenue over the next 8 years is 118%.
